FAQs about Provider Profiles on Breast Cancer Screenings (Mammography) Q: Who receives a profile on breast cancer screenings (mammograms)?

Similar documents
18 Week 92% Open Pathway Recovery Plan and Backlog Clearance

Jan Feb Mar Apr May Jun Jul Aug Sep X X X X X X X. Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov X X X X X X X X X X X X X

FGSZ Zrt. from 28 February 2019 till 29 February 2020 AUCTION CALENDAR: YEARLY YEARLY BUNDLED AT CROSS BORDER POINTS

Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Breast Test Wales Screening Division Public Health Wales

Curators of the University of Missouri - Combined January 01, 2013 through December 31, 2013 Cost Management Report

Curators of the University of Missouri - Combined January 1, 2016 through December 31, 2016

FFT and Patient Insight for Improvement. Marie Allen Head of Service User and Carer Experience

Overview of the Radiation Exposure Doses of the Workers at Fukushima Daiichi Nuclear Power Station

Consultant-led Referral to Treatment (RTT) waiting times collection timetable: outcome of consultation

McLean ebasis plus TM

Tri-County Opioid Safety Coalition Data Brief December 2017 Clackamas, Multnomah, and Washington Counties

BREATH AND BLOOD ALCOHOL STATISTICS

Dementia Content Report January Produced By The NHS Choices Reporting Team

Sleep Market Panel. Results for June 2015

HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE

Global Fund Approach to Health System Strengthening

The CIDRZ Experience: use of data to understand patient outcomes and guide program implementation 07 January 2010

STRENGTHENING THE COORDINATION, DELIVERY AND MONITORING OF HIV AND AIDS SERVICES IN MALAWI THROUGH FAITH-BASED INSTITUTIONS.

Complete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation Well Beyond 6-Month Reporting

Has the UK had a double epidemic?

Dementia Content Report May Produced By The NHS Choices Reporting Team

th Medical Group Report Card

Utilizing CQI to Improve the Health of Supportive Housing Residents The North American Housing and HIV/AIDS Research Summit VII September 25-27, 2013

Quit Rates of New York State Smokers

Insulin Administration Errors in Adult Community Nursing. Hedy Lehman Assistant Director of Professional Standards, Adult Community Nursing

CONTROL CHART METHODOLOGY

Lauren DiBiase, MS, CIC Associate Director Public Health Epidemiologist Hospital Epidemiology UNC Hospitals

From Analytics to Action

Cincinnati Children s Hospital Medical Center PHO/OVPCA Constipation Initiative Monthly Report February 2018

CURRICULUM PACING CHART ACES Subject: Science-Second Grade

Figure 1: Quantity Dispensed/100 Members (Ambien and Sonata on left axis)

Durham Region Influenza Bulletin: 2017/18 Influenza Season

Welcome to Your DSA Action Team Meeting. February 29, 2012

APPENDIX ONE. 1 st Appointment (Non-admitted) recovery trajectories

Timetable detailed schedule Term 3 and

University of Pittsburgh Critical Care Medicine

Dry Needling (DN) Registration

Cancer Immunotherapy Pilot Program/ Patents 4 Patients. USPTO BCP Customer Partnership Meeting Alexandria, VA August 2, 2017

IHN-CCO DST Final Report and Evaluation

BJA Performance Measures

Pre-hospital thrombolysis (PHT) Clinical Audit Report 30 th November 2007

Date : September Permit/License or Registration Application. Permit/License/ Notification/ Registration Description. Remark

Measure Up/Pressure Down Medical Group Success

Chi-Square Goodness-of-Fit Test

Spring Understanding the potential of generic substitution

FOOD BANK UPDATE: PARSON CROSS INITIATIVE PROJECTS

Sexual Health Content Report June Produced By The NHS Choices Reporting Team

One Palliative Care Annual Report

Crisis Connections Crisis Line Phone Worker Training (Online/Onsite) Winter 2019

South Plains Emergency Medical Services, Inc. P.O. Box Lubbock, Texas 79453

IMPLEMENTING RECOVERY ORIENTED CLINICAL SERVICES IN OPIOID TREATMENT PROGRAMS PILOT UPDATE. A Clinical Quality Improvement Program

RTT Exception Report

Portfolio Strategy Group

Portfolio Strategy Group

CAPL 2 Questionnaire

Avian influenza in poultry, wild and captive birds (AI)

The PROMs Programme in the NHS in England

LUNG ALLOCATION SCORE SYSTEM UPDATE

Poster Session HRT1317 Innovation Awards November 2013 Brisbane

Analysis of Meter Reading Validation Tolerances proposed by Project Nexus

EDINBURGH HEALTHCARE NHS TRUST. 4 Edinburgh Healthcare NHS Trust Printed Material,

Education around PML risk and monitoring at NHNN Queen Square MS Centre

Emergency Department Boarding of Psychiatric Patients in Oregon

INTERNATIONAL LIPOPROTEIN STANDARDIZATION FORUM Fasting Time and Lipid Levels in a Community-Based Population: A Crosssectional

Understanding the Role of Palliative Care in the Treatment of Cancer Patients

Data Visualization - Basics

Measure #112 (NQF 2372): Breast Cancer Screening National Quality Strategy Domain: Effective Clinical Care

Published by the Pharmaceutical Services Division to provide information for British Columbia s health care providers

Texas Vendor Drug Program Specialty Drug List Process. February 2019

East London Community Kidney Service

An Updated Approach to Colon Cancer Screening and Prevention

Kansas EMS Naloxone (Narcan) Administration

Seasonality of influenza activity in Hong Kong and its association with meteorological variations

North Dakota Board of Pharmacy

Regular Courses 2019

Monitoring Protocol for Clozapine-induced Myocarditis. Copyright 2017, CAMH

ACUTE LYMPHOBLASTIC LEUKEMIA

KPI s September Megan Boivin Operations Manager 15 October KPI s HAC report 18/10/2007 Operations Manager : Megan Boivin

AccuSet HIV-1/2 Performance Panel

Hand, Foot, and Mouth Disease Situation Update. Hand, Foot, and Mouth Disease surveillance summary

Organ Donation Breakthrough Collaborative Institute of Medicine

NORTHERN HEALTH AND SOCIAL CARE TRUST. Waiting Times Summary Report

Marketing on a Budget: Monthly quit & win challenges to drive quitline utilization. Presenters: John Atkinson & Elizabeth Harvey

Clostridium difficile (C. difficile) and Staphylococcus aureus bacteraemia (MRSA and MSSA) Bi-annual Report. Surveillance: Report:

Regular Courses 2017

End Stage Renal Disease (ESRD) Network Learning and Action Network (LAN) Series: Bloodstream Infection (BSI) Quality Improvement Activity

TB Outbreak in a Homeless Shelter

MICHIGAN PATHOLOGY QUALITY SYSTEM (MPQS)

Turbulence Accidents and NTSB Research Update. Nathan Doble Turbulence Impact Mitigation Workshop 3 McLean, Virginia September 6, 2018

March 2012: Next Review September 2012

BSA New Zealand Hawkes Bay District Health Board Coverage Report

Commissioning Chemotherapy Services Conference. Issues of consent in systemic therapy

Supplementary Online Content

2017 Performance Recognition Program PROVIDER INCENTIVE PROGRAM FOR: BCN HMO SM Commercial BCN Advantage SM Blue Cross Medicare Plus Blue SM PPO

UNDERSTANDING NEW HAMPSHIRE DENTAL CLAIMS DATA

Weekly Influenza News 2016/17 Season. Communicable Disease Surveillance Unit. Summary of Influenza Activity in Toronto for Week 43

Winter Holiday Suicide Myth Continues to be Reinforced in Press Annenberg Public Policy Center Study Finds

EQAS. Hemoglobin Program (BC80) Cycle 12: December 2014 December 2015 Sample No: 1 Sample Date: 17 Dec 14. Exceptions. Customer Information

Transcription:

FAQs about Provider Profiles on Breast Cancer Screenings (Mammography) Q: Who receives a profile on breast cancer screenings (mammograms)? A: We send letters and/or profiles to PCPs with female members 40 years and older assigned to their panel for five or more months. If the provider has enough data for a valid statistical profile, s/he will receive a letter and a profile. If not, the provider receives a letter saying s/he had insufficient data for a valid profile. Q: I am a provider with more than one service location. How does this impact my profile for Breast Cancer Screenings? A: The profiles for mammograms are not tied to the service location; the profiles combine the results from all service locations so that providers will be more likely to have enough data for a statistical profile. Your profile combines the results for all women 40 years and older who are assigned to any of your service locations for five or more months. Q: How often are the profiles for Breast Cancer Screenings created? A: We send out profiles twice a year. The review period for one profile covers the calendar year, and the review period for the other profile is the state fiscal year (July 1-June 30). We wait at least 90 days after the review period to allow time for all claims to be paid. Q: How does the OHCA count the number of members assigned to the panel? My records show a lower number on my panel. A: We identify members 40 years and older who were assigned to your panel for five or more months (150 days) during the review period. At any given time, you may have fewer members than the total shown on your profile. For example, Member A might be on the panel for six months (for example, January through June); Member B is on the panel for six months (July through December); and Member C is on the panel every month except for April and May. In this example, the provider would count only one or two members on the panel during any given month, even though during the year a total of three members would be counted for the profile. The table below illustrates this example; a zero indicates the member was not assigned to the panel that month, and a one shows the member was counted on the panel. Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Member A 1 1 1 1 1 1 0 0 0 0 0 0 Member B 0 0 0 0 0 0 1 1 1 1 1 1 Member C 1 1 1 0 0 1 1 1 1 1 1 1 Monthly Totals 2 2 2 1 1 2 2 2 2 2 2 1 1

Q: What are Female Member Months? A: This is the total number of months that the identified women have been assigned to you. In the example above for Members A, B and C, the total member months would be 6+6+10 = 22. Q: What is meant by Observed Number of Members with Mammograms? A: For the members who were counted in the Number of Female Members, the Observed Number of Members with Mammograms reports how many of them received a screening during the review period. Q: What if some of my patients have seen another provider for a mammogram? Am I being held responsible for them? A: We are linking you with the members assigned to you, but you are getting credit for the mammogram that your members received from any SoonerCare provider during the time they were on your panel. 2

Q: My profile shows an Expected Number of Members with Mammograms equal to 28.5. How is this number calculated? A: We also take into account the number of women on the panel and how long each woman was assigned to your panel. We begin by counting only those women who have been assigned to your panel for five or more months. Then the number of months each woman has been assigned to your panel is used in our calculations. Our calculations of the Expected Number of Members with Mammograms involve a statistical procedure called logistic regression, which is similar to linear regression except it is intended for use with yes/no kinds of data that is, whether a member received a breast cancer screening or not. The member s age and the number of months she was assigned to a panel both contributed to the explanation of whether she received a mammogram. By combining data for members from across the state, we can compute the number of members of different ages with different lengths of eligibility we might expect to receive mammograms, based on actual rates for SoonerCare Choice members. Historically this has meant that the older a panel member is, the higher the expectation is that a mammogram has been performed. We understand that this is a complicated procedure, but we believe it is the best statistical approach. If you would like more information on this use of logistic regression, please contact the Quality Assurance and Improvement Department of the OHCA at (405) 522-7672. 3

Q: What is the Observed-to-Expected Ratio? A: The O/E Ratio is the first step toward determining whether the provider has met expectations. This number is calculated by taking the Observed Number of Members with Mammograms and dividing it by the Expected Number of Members with Mammograms. In the example showed here, Dr. Provider s panel included 43 women with at least five months of eligibility. These women had a total of 346 months of eligibility. The Observed Number of Members with Mammograms was 10, and the Expected Number of Members with Mammograms was 5.3. By dividing 10 by 5.3, we obtain the O/E Ratio = 1.88. (The profile reports rounded numbers; unrounded numbers are used to calculate the O/E Ratio.) An O/E Ratio of 1.88 means that the provider was credited with providing the service to 1.88 members for every member who was expected to receive the screening. 4

Q: How is the O/E Ratio used? A: We use the O/E Ratio to compute a confidence interval, a statistic that helps us determine whether the Observed and the Expected numbers of members with mammograms are statistically the same or if the difference is statistically big. A confidence interval is similar to a margin of error, which is used in opinion polls; a margin of error may be used to determine whether one candidate s approval rating is significantly higher than another candidate s rating, or if the two candidates approval ratings are so close that they are statistically equal. If the O/E Ratio perfectly equals one, then we know that expectations were met that is, the observed number of members with mammograms and the expected number of members with mammograms were the same. But the observed and expected numbers could be close enough that we can t tell them apart statistically or the observed number could be significantly lower than the expected number. These questions are answered by use of a confidence interval around the O/E Ratio. Q: How do you decide whether I have met expectations? The confidence interval (not reported on the Provider Profile) is based on your data, not the data from any other provider. Like many test statistics, which are used to make decisions, the confidence interval takes into account that there will be some variation between the observed and the expected numbers. The confidence interval provides a range of values around the O/E Ratio. If the confidence interval brackets the number 1 (reminding you that the number 1 means the observed and expected numbers are equal), then the observed number is statistically the same as the expected number. We can provide more information on the calculation of the confidence interval upon request; please contact the Quality Assurance and Improvement Department of the OHCA at (405) 522-7672. Q: What is the Rank on the profile? 5

A: We assign rank by placing all providers with sufficient data in order according to the O/E Ratio. The provider with the largest O/E Ratio (that is, with the highest ratio of the observed-to-expected numbers of members receiving mammograms) is ranked first. Q: The profile has a graph, and one bar is shown in a different color. Why? A: This bar indicates where your O/E Ratio is located, relative to other providers who had enough data for a valid profile to be created for this review period. The O/E Ratio for providers with higher ranks will be toward the right side of the graph; lower-ranked providers O/E Ratios will be toward the left side of the graph. Q: I received a letter saying there was not enough data for a profile to be created. How much data do you need? A: If you received a low data letter, then the calculations showed that fewer than five women on your panel were expected to receive a screening. This is insufficient to create a valid statistical profile. Q: What if I have other questions that you haven t covered here? A: Please contact our Quality Assurance and Improvement Department at (405) 522-7672. 6